Get started
Author

Patricia V. Nash

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
2021 · Christine G. Lee, Brandy Heckman-Stoddard, et al. · Diabetes Care · 102
The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures
2020 · Andrea M. Kriska, Bonny Rockette-Wagner, et al. · Diabetes Care · 70
PDF
Effect of spaceflight on lymphocyte proliferation and interleukin-2 production
1992 · P. V. Nash, I. V. Konstantinova, et al. · Journal of Applied Physiology · 54
Variable lymphocyte responses in rats after space flight
1992 · Patricia V. Nash, Andrea M. Mastro · Experimental Cell Research · 48
Variability in Heparin Sensitivity of APTT Reagents
1986 · Thorir D. Bjornsson, Patricia V. Nash · American Journal of Clinical Pathology · 41
Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience
2022 · Neil H. White, Qing Pan, et al. · Diabetes Care · 34
PDF
Effect of hindlimb suspension simulation of microgravity on in vitro immunological responses*1
1991 · P NASH · Experimental Cell Research · 31
The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact
2025 · Jill P. Crandall, Dana Dabelea, et al. · Diabetes Care · 28
PDF
Association of Metformin With the Development of Age-Related Macular Degeneration
2022 · Amitha Domalpally, Samuel A. Whittier, et al. · JAMA Ophthalmology · 25
Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)
2022 · Josephine H. Li, James A. Perry, et al. · Diabetes · 20
PDF
Kinetics and metabolism of sulfinpyrazone
1983 · Cheryl Mahony, Katherine M Wolfram, et al. · Clinical Pharmacology & Therapeutics · 20
Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH
2023 · Josephine H. Li, Laura N. Brenner, et al. · Diabetologia · 19
PDF
B-Lymphocyte Responses in the Large Intestine and Mesenteric Lymph Nodes of Mice Infected with Eimeria falciformis (Apicomplexa)
1988 · Patricia V. Nash, C. A. Speer · Journal of Parasitology · 14
Activation of primary lymphocytes requires prolonged lectin stimulation
1993 · Patricia V Nash, Andrea M Mastro · Journal of Leukocyte Biology · 12
Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure
2024 · Christine G. Lee, Adam Ciarleglio, et al. · Diabetes Care · 10
PDF
Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks
2025 · Emily Kobayashi, Nathaniel J. Linden-Santangeli, et al. · Diabetes Care · 9
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience
2022 · Neil H. White, Qing Pan, et al. · Diabetes Care · 8
PDF
The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS)
2022 · Marissa M. Shams-White, Ashley H. Tjaden, et al. · BMC Nutrition · 5
PDF
Determination of plasma heparin by polybrene neutralization
1984 · Patricia V. Nash, Thorir D. Bjornsson · Analytical Biochemistry · 5
Lifestyle and Metformin Interventions and Risk of Multimorbidity in Adults With Prediabetes
2026 · Marcel E. Salive, Ashley H. Tjaden, et al. · JAMA · 3
Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS)
2025 · Ashley H. Tjaden, Barbara H. Braffett, et al. · Diabetes Care · 2
Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
2025 · William H. Herman, Adam Ciarleglio, et al. · Diabetes Care · 2
Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study
2025 · Samuel Dagogo-Jack, Erin J. Kazemi, et al. · Diabetes Care
Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study
2025 · William C. Knowler, Qing Pan, et al. · Diabetes Care
Experiment K-7-23: Effect of Spaceflight on Level and Function of Immune Cells. Part 2; Proliferation and Cytokines
1994 · Patricia V. Nash, Irena Konstantinova, et al. · NASA Technical Reports Server (NASA)
Works count: 25
Citation count: 562
H-index: 13
I10-index: 15
Year
Topic
Type